Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study

被引：0
|
作者：
Glauce Cordeiro Ulhôa Tostes
Maria Rosário Cunha
Rosa Tsumeshiro Fukui
Márcia Regina Silva Correia
Dalva Marreiro Rocha
Rosa Ferreira dos Santos
Maria Elizabeth Rossi da Silva
机构：
[1] Universidade de São Paulo,Laboratório de Carboidratos e Radioimunoensaios LIM
来源：
Diabetology & Metabolic Syndrome | / 8卷
关键词：
Nateglinide; Rosiglitazone; GLP-1; Haemostatic factors; Inflammatory markers; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study
    Ulhoa Tostes, Glauce Cordeiro
    Cunha, Maria Rosario
    Fukui, Rosa Tsumeshiro
    Silva Correia, Marcia Regina
    Rocha, Dalva Marreiro
    dos Santos, Rosa Ferreira
    Rossi da Silva, Maria Elizabeth
    DIABETOLOGY & METABOLIC SYNDROME, 2016, 8
  • [2] Molecular mechanisms redirecting the GLP-1 receptor signalling profile in pancreatic beta-cells during type 2 diabetes
    Roussel, Morgane
    Mathieu, Julia
    Dalle, Stephane
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2016, 26 (02) : 87 - 95
  • [3] Effects of GLP-1 receptor agonists on mitochondrial function, inflammatory markers and leukocyte-endothelium interactions in type 2 diabetes
    Luna-Marco, Clara
    de Maranon, Arantxa M.
    Hermo-Argibay, Alberto
    Rodriguez-Hernandez, Yohaly
    Hermenejildo, Jonathan
    Fernandez-Reyes, Meylin
    Apostolova, Nadezda
    Vila, Jose
    Sola, Eva
    Morillas, Carlos
    Rovira-Llopis, Susana
    Rocha, Milagros
    Victor, Victor M.
    REDOX BIOLOGY, 2023, 66
  • [4] Effects of short-term metformin and rosiglitazone treatment on GLP-1, leptin and adiponectin levels in patients with type 2 diabetes mellitus
    Alphan, Z.
    Gullu, S.
    DIABETOLOGIA, 2006, 49 : 339 - 339
  • [5] Effects of GLP-1 receptor agonists on myokine levels and pro-inflammatory cytokines in patients with type 2 diabetes mellitus
    Guarnotta, Valentina
    Bianco, Maria J.
    Vigneri, Enrica
    Panto, Felicia
    Lo Sasso, Bruna
    Ciaccio, Marcello
    Pizzolanti, Giuseppe
    Giordano, Carla
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2021, 31 (11) : 3193 - 3201
  • [6] Tirzepatide, a dual GIP and GLP-1 receptor agonist, improves markers of beta cell function and insulin sensitivity in type 2 diabetes patients
    Thomas, M. K.
    Nikooienejad, A.
    Bray, R.
    Cui, X.
    Wilson, J.
    Duffin, K.
    Milicevic, Z.
    Haupt, A.
    Robins, D. A.
    DIABETOLOGIA, 2019, 62 : S354 - S354
  • [7] GLP-1 suppresses glucagon secretion in human pancreatic alpha-cells by inhibition of P/Q-type Ca2+ channels
    Ramracheya, Reshma
    Chapman, Caroline
    Chibalina, Margarita
    Dou, Haiqiang
    Miranda, Caroline
    Gonzalez, Alejandro
    Moritoh, Yusuke
    Shigeto, Makoto
    Zhang, Quan
    Braun, Matthias
    Clark, Anne
    Johnson, Paul R.
    Rorsman, Patrik
    Briant, Linford J. B.
    PHYSIOLOGICAL REPORTS, 2018, 6 (17):
  • [8] Effects of GLP-1 Receptor Agonists on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus: A 52-Week Clinical Study
    Cai, Ting-ting
    Li, Hui-qin
    Jiang, Lan-lan
    Wang, Hui-ying
    Luo, Meng-hui
    Su, Xiao-fei
    Ma, Jian-hua
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [9] Effects of prebiotics on postprandial GLP-1, GLP-2 and glucose regulation in patients with type 2 diabetes: A randomised, double-blind, placebo-controlled crossover trial
    Birkeland, Eline
    Gharagozlian, Sedegheh
    Gulseth, Hanne L.
    Birkeland, Kare, I
    Hartmann, Bolette
    Holst, Jens J.
    Holst, Rene
    Aas, Anne-Marie
    DIABETIC MEDICINE, 2021, 38 (10)
  • [10] Tirzepatide, a Dual GIP and GLP-1 Receptor Agonist, Improves Markers of Beta-Cell Function and Insulin Sensitivity in Type 2 Diabetes Patients
    Thomas, Melissa K.
    Nikooienejad, Amir
    Bray, Ross
    Cui, Xuewei
    Wilson, Jonathan M.
    Duffin, Kevin L.
    Milicevic, Zvonko
    Haupt, Axel
    Robins, Deborah A.
    DIABETES, 2019, 68
12345